{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T07:09:19Z","timestamp":1789456159615,"version":"build-2803163510"},"reference-count":48,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T00:00:00Z","timestamp":1781740800000},"content-version":"vor","delay-in-days":168,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","cmghjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cellular and Molecular Gastroenterology and Hepatology"],"published-print":{"date-parts":[[2026]]},"DOI":"10.1016\/j.jcmgh.2026.101837","type":"journal-article","created":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T15:26:43Z","timestamp":1782314803000},"page":"101837","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["IGF2BP1-Mediated m\u2076A Modification Stabilizes HMGA2 mRNA to Promote Intrahepatic Cholangiocarcinoma Progression"],"prefix":"10.1016","volume":"20","author":[{"given":"Yu","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Le","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaiheng","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangyu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanfeng","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meiping","family":"Ni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jixuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keyu","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qimeng","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengjie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingxiu","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaoqun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoting","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2433-7199","authenticated-orcid":false,"given":"Qiongzhu","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcmgh.2026.101837_bib1","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.jhep.2019.10.009","article-title":"Systemic therapies for intrahepatic cholangiocarcinoma","volume":"72","author":"Kelley","year":"2020","journal-title":"J Hepatol"},{"key":"10.1016\/j.jcmgh.2026.101837_bib2","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.jhep.2019.11.020","article-title":"Liver resection and transplantation for intrahepatic cholangiocarcinoma","volume":"72","author":"Mazzaferro","year":"2020","journal-title":"J Hepatol"},{"key":"10.1016\/j.jcmgh.2026.101837_bib3","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/S1470-2045(24)00082-2","article-title":"Durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer (TOPAZ-1): patient-reported outcomes from a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"25","author":"Burris","year":"2024","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jcmgh.2026.101837_bib4","first-page":"198","article-title":"Advances in the treatment of intrahepatic cholangiocarcinoma: An overview of the current and future therapeutic landscape for clinicians","volume":"73","author":"Moris","year":"2023","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.jcmgh.2026.101837_bib5","doi-asserted-by":"crossref","first-page":"396","DOI":"10.3350\/cmh.2021.0287","article-title":"Intrahepatic cholangiocarcinoma: Tumour heterogeneity and its clinical relevance","volume":"28","author":"Komuta","year":"2022","journal-title":"Clin Mol Hepatol"},{"key":"10.1016\/j.jcmgh.2026.101837_bib6","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1053\/j.gastro.2013.10.013","article-title":"Pathogenesis, diagnosis, and management of cholangiocarcinoma","volume":"145","author":"Ilyas","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jcmgh.2026.101837_bib7","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1158\/1078-0432.CCR-14-3296","article-title":"Molecular pathogenesis and targeted therapies for intrahepatic cholangiocarcinoma","volume":"22","author":"Moeini","year":"2016","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jcmgh.2026.101837_bib8","doi-asserted-by":"crossref","first-page":"269","DOI":"10.3390\/genes12020269","article-title":"HMGA2 as a critical regulator in cancer development","volume":"12","author":"Mansoori","year":"2021","journal-title":"Genes (Basel)"},{"key":"10.1016\/j.jcmgh.2026.101837_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2023.106732","article-title":"HMGA2 regulation by miRNAs in cancer: Affecting cancer hallmarks and therapy response","volume":"190","author":"Hashemi","year":"2023","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.jcmgh.2026.101837_bib10","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1158\/0008-5472.CAN-15-1287","article-title":"Mesenchymal tumorigenesis driven by TSC2 haploinsufficiency requires HMGA2 and is independent of mTOR pathway activation","volume":"76","author":"D'Armiento","year":"2016","journal-title":"Cancer Res"},{"key":"10.1016\/j.jcmgh.2026.101837_bib11","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1158\/0008-5472.CAN-21-1222","article-title":"Integrated molecular characterization of patient-derived models reveals therapeutic strategies for treating CIC-DUX4 Sarcoma","volume":"82","author":"Carrabotta","year":"2022","journal-title":"Cancer Res"},{"key":"10.1016\/j.jcmgh.2026.101837_bib12","doi-asserted-by":"crossref","first-page":"4858","DOI":"10.1093\/nar\/gkaa232","article-title":"The regulation of acetylation and stability of HMGA2 via the HBXIP-activated Akt-PCAF pathway in promotion of esophageal squamous cell carcinoma growth","volume":"48","author":"Wu","year":"2020","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jcmgh.2026.101837_bib13","doi-asserted-by":"crossref","first-page":"4866","DOI":"10.1038\/s41467-025-60129-1","article-title":"HMGA2 and protein leucine methylation drive pancreatic cancer lineage plasticity","volume":"16","author":"Dobersch","year":"2025","journal-title":"Nat Commun"},{"key":"10.1016\/j.jcmgh.2026.101837_bib14","doi-asserted-by":"crossref","first-page":"963","DOI":"10.7150\/thno.65411","article-title":"HMGA2 facilitates colorectal cancer progression via STAT3-mediated tumor-associated macrophage recruitment","volume":"12","author":"Wang","year":"2022","journal-title":"Theranostics"},{"key":"10.1016\/j.jcmgh.2026.101837_bib15","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.suronc.2019.01.013","article-title":"The expressions of HMGA2 and Thy1 in extrahepatic cholangiocarcinoma and their clinicopathological significances","volume":"29","author":"Liu","year":"2019","journal-title":"Surg Oncol"},{"key":"10.1016\/j.jcmgh.2026.101837_bib16","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.ejso.2020.08.005","article-title":"Significance of HMGA2 expression as independent poor prognostic marker in perihilar and distal cholangiocarcinoma resected with curative intent","volume":"47","author":"Takahashi","year":"2021","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.jcmgh.2026.101837_bib17","doi-asserted-by":"crossref","first-page":"2334","DOI":"10.1016\/j.humpath.2014.04.026","article-title":"High-mobility group AT-hook 2: an independent marker of poor prognosis in intrahepatic cholangiocarcinoma","volume":"45","author":"Lee","year":"2014","journal-title":"Hum Pathol"},{"key":"10.1016\/j.jcmgh.2026.101837_bib18","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/s12943-020-01207-4","article-title":"Interaction between N(6)-methyladenosine (m(6)A) modification and noncoding RNAs in cancer","volume":"19","author":"Chen","year":"2020","journal-title":"Mol Cancer"},{"key":"10.1016\/j.jcmgh.2026.101837_bib19","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s40164-023-00386-2","article-title":"Emerging roles of m6A RNA modification in cancer therapeutic resistance","volume":"12","author":"Liu","year":"2023","journal-title":"Exp Hematol Oncol"},{"key":"10.1016\/j.jcmgh.2026.101837_bib20","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/s12943-023-01792-0","article-title":"IGF2BP1 induces neuroblastoma via a druggable feedforward loop with MYCN promoting 17q oncogene expression","volume":"22","author":"Hagemann","year":"2023","journal-title":"Mol Cancer"},{"key":"10.1016\/j.jcmgh.2026.101837_bib21","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1038\/s41467-023-37542-5","article-title":"PRMT3-mediated arginine methylation of IGF2BP1 promotes oxaliplatin resistance in liver cancer","volume":"14","author":"Shi","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.jcmgh.2026.101837_bib22","article-title":"Aldolase A accelerates cancer progression by modulating mRNA translation and protein biosynthesis via Noncanonical Mechanisms","volume":"10","author":"Song","year":"2023","journal-title":"Adv Sci (Weinh)"},{"key":"10.1016\/j.jcmgh.2026.101837_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216075","article-title":"IGF2BP1-mediated N6-methyladenosine modification promotes intrahepatic cholangiocarcinoma progression","volume":"557","author":"Xiao","year":"2023","journal-title":"Cancer Lett"},{"key":"10.1016\/j.jcmgh.2026.101837_bib24","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abg3750","article-title":"Comprehensive analysis of spatial architecture in primary liver cancer","volume":"7","author":"Wu","year":"2021","journal-title":"Sci Adv"},{"key":"10.1016\/j.jcmgh.2026.101837_bib25","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1158\/1078-0432.CCR-18-0284","article-title":"Combined CDK4\/6 and Pan-mTOR inhibition is synergistic against intrahepatic cholangiocarcinoma","volume":"25","author":"Song","year":"2019","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jcmgh.2026.101837_bib26","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1053\/j.gastro.2022.05.007","article-title":"NOTCH-YAP1\/TEAD-DNMT1 axis drives hepatocyte reprogramming into intrahepatic cholangiocarcinoma","volume":"163","author":"Hu","year":"2022","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jcmgh.2026.101837_bib27","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.jhep.2022.02.030","article-title":"Loss of SIRT5 promotes bile acid-induced immunosuppressive microenvironment and hepatocarcinogenesis","volume":"77","author":"Sun","year":"2022","journal-title":"J Hepatol"},{"key":"10.1016\/j.jcmgh.2026.101837_bib28","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1038\/s41568-020-0253-2","article-title":"Role of RNA modifications in cancer","volume":"20","author":"Barbieri","year":"2020","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.jcmgh.2026.101837_bib29","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1186\/s12943-024-02089-6","article-title":"Writers, readers, and erasers RNA modifications and drug resistance in cancer","volume":"23","author":"Chen","year":"2024","journal-title":"Mol Cancer"},{"key":"10.1016\/j.jcmgh.2026.101837_bib30","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/s41571-023-00774-x","article-title":"The roles and implications of RNA m(6)A modification in cancer","volume":"20","author":"Deng","year":"2023","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.jcmgh.2026.101837_bib31","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/s41556-018-0045-z","article-title":"Recognition of RNA N(6)-methyladenosine by IGF2BP proteins enhances mRNA stability and translation","volume":"20","author":"Huang","year":"2018","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.jcmgh.2026.101837_bib32","doi-asserted-by":"crossref","first-page":"4334","DOI":"10.1093\/nar\/gkz136","article-title":"IMP1 KH1 and KH2 domains create a structural platform with unique RNA recognition and re-modelling properties","volume":"47","author":"Dagil","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jcmgh.2026.101837_bib33","doi-asserted-by":"crossref","first-page":"8774","DOI":"10.1093\/nar\/gkad534","article-title":"Direct m6A recognition by IMP1 underlays an alternative model of target selection for non-canonical methyl-readers","volume":"51","author":"Nicastro","year":"2023","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jcmgh.2026.101837_bib34","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/s41392-020-00450-x","article-title":"The role of m6A modification in the biological functions and diseases","volume":"6","author":"Jiang","year":"2021","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.jcmgh.2026.101837_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216510","article-title":"TRIM29 promotes antitumor immunity through enhancing IGF2BP1 ubiquitination and subsequent PD-L1 downregulation in gastric cancer","volume":"581","author":"Jiang","year":"2024","journal-title":"Cancer Lett"},{"key":"10.1016\/j.jcmgh.2026.101837_bib36","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/s41392-021-00828-5","article-title":"Targeting PI3K\/Akt signal transduction for cancer therapy","volume":"6","author":"He","year":"2021","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.jcmgh.2026.101837_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2024.156022","article-title":"Hypocrellin A against intrahepatic cholangiocarcinoma via multi-target inhibition of the PI3K-AKT-mTOR, MAPK, and STAT3 signaling pathways","volume":"135","author":"Chen","year":"2024","journal-title":"Phytomedicine"},{"key":"10.1016\/j.jcmgh.2026.101837_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2025.156690","article-title":"Fufang-Biejia-Ruangan tablet targeting both cancer-associated fibroblasts and tumor cells by HIPPO-PI3K\/AKT cascades in intrahepatic cholangiocarcinoma treatment","volume":"141","author":"Xu","year":"2025","journal-title":"Phytomedicine"},{"key":"10.1016\/j.jcmgh.2026.101837_bib39","doi-asserted-by":"crossref","first-page":"4695","DOI":"10.1038\/s41467-019-12651-2","article-title":"N(6)-methyladenosine modification of circNSUN2 facilitates cytoplasmic export and stabilizes HMGA2 to promote colorectal liver metastasis","volume":"10","author":"Chen","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.jcmgh.2026.101837_bib40","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1016\/j.apsb.2024.01.006","article-title":"Blockade of the deubiquitinating enzyme USP48 degrades oncogenic HMGA2 and inhibits colorectal cancer invasion and metastasis","volume":"14","author":"Cheng","year":"2024","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.jcmgh.2026.101837_bib41","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.tig.2022.10.004","article-title":"Genetic and epigenetic defects of the RNA modification machinery in cancer","volume":"39","author":"Orsolic","year":"2023","journal-title":"Trends Genet"},{"key":"10.1016\/j.jcmgh.2026.101837_bib42","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s12943-022-01500-4","article-title":"The role of m6A RNA methylation in cancer metabolism","volume":"21","author":"An","year":"2022","journal-title":"Mol Cancer"},{"key":"10.1016\/j.jcmgh.2026.101837_bib43","article-title":"Disruption of MerTK increases the efficacy of checkpoint inhibitor by enhancing ferroptosis and immune response in hepatocellular carcinoma","volume":"5","author":"Wang","year":"2024","journal-title":"Cell Rep Med"},{"key":"10.1016\/j.jcmgh.2026.101837_bib44","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.1158\/2159-8290.CD-21-1640","article-title":"Geospatial immune heterogeneity reflects the diverse tumor-immune interactions in intrahepatic cholangiocarcinoma","volume":"12","author":"Lin","year":"2022","journal-title":"Cancer Discov"},{"key":"10.1016\/j.jcmgh.2026.101837_bib45","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.ccell.2021.12.006","article-title":"Proteogenomic characterization identifies clinically relevant subgroups of intrahepatic cholangiocarcinoma","volume":"40","author":"Dong","year":"2022","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jcmgh.2026.101837_bib46","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/s41392-024-01761-z","article-title":"Alpha5 nicotine acetylcholine receptor subunit promotes intrahepatic cholangiocarcinoma metastasis","volume":"9","author":"Fu","year":"2024","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.jcmgh.2026.101837_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.112666","article-title":"Modulation of cellular metabolism by protein crotonylation regulates pancreatic cancer progression","volume":"42","author":"Zheng","year":"2023","journal-title":"Cell Rep"},{"key":"10.1016\/j.jcmgh.2026.101837_bib48","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1136\/gutjnl-2022-327230","article-title":"Targeting tumour-intrinsic N(7)-methylguanosine tRNA modification inhibits MDSC recruitment and improves anti-PD-1 efficacy","volume":"72","author":"Liu","year":"2023","journal-title":"Gut"}],"container-title":["Cellular and Molecular Gastroenterology and Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352345X26001153?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352345X26001153?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T06:24:29Z","timestamp":1789453469000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352345X26001153"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":48,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026]]}},"alternative-id":["S2352345X26001153"],"URL":"https:\/\/doi.org\/10.1016\/j.jcmgh.2026.101837","relation":{},"ISSN":["2352-345X"],"issn-type":[{"value":"2352-345X","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"IGF2BP1-Mediated m\u2076A Modification Stabilizes HMGA2 mRNA to Promote Intrahepatic Cholangiocarcinoma Progression","name":"articletitle","label":"Article Title"},{"value":"Cellular and Molecular Gastroenterology and Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcmgh.2026.101837","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of American Gastroenterological Association Institute.","name":"copyright","label":"Copyright"}],"article-number":"101837"}}